Literature DB >> 3755544

Exocytosis from large dense cored vesicles as a mechanism for neuropeptide release in the peripheral and central nervous system.

A Thureson-Klein, R L Klein, P C Zhu.   

Abstract

Nerve terminals often contain morphologically distinct populations of large (75-110 nm) and small (45-55 nm) vesicles. The small vesicles are speculated to account for release of transmitter quanta as they accumulate at presynaptic membranes. Large vesicles can co-store neuropeptides and classical transmitters but their function in neurotransmission has been disputed because they do not appear to accumulate at chemical synapses. However, there is now evidence that the large vesicles play a role in neurotransmission or its modulation even though they may not be eminently involved in synaptic release. Thus, exocytosis occurs along the synapse-lacking membranes of peripheral noradrenergic varicosities. Large vesicles may continue to function in peptide release even after the classical transmitter has been depleted as demonstrated in the pig vas deferens. Three days of reserpine administration causes a parallel loss of noradrenaline and small vesicle contents but does not decrease enkephalin-like immunoreactivity or large vesicle electron density. In the central nervous system of the rat, where substance P and enkephalin have been localized to large vesicles, exocytosis occurs from several types of terminals. The large vesicles appear preferentially to release their contents at morphologically non-specialized sites even when characteristic synapses are present. Thus different mechanisms of transmitter and neuropeptide release may coexist. The nonsynaptic discharge may allow substances to diffuse over a wider distance whereas release into a synaptic cleft could restrict receptor interaction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3755544

Source DB:  PubMed          Journal:  Scan Electron Microsc        ISSN: 0586-5581


  9 in total

1.  Ultrastructural localization of extranuclear progestin receptors relative to C1 neurons in the rostral ventrolateral medulla.

Authors:  Teresa A Milner; Katherine L Mitterling; Costantino Iadecola; Elizabeth M Waters
Journal:  Neurosci Lett       Date:  2007-12-03       Impact factor: 3.046

Review 2.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents.

Authors:  B A S Reyes; G Drolet; E J Van Bockstaele
Journal:  J Comp Neurol       Date:  2008-06-01       Impact factor: 3.215

Review 4.  Structure activity relationship of synaptic and junctional neurotransmission.

Authors:  Raj K Goyal; Arun Chaudhury
Journal:  Auton Neurosci       Date:  2013-03-25       Impact factor: 3.145

Review 5.  Putative roles of neuropeptides in vagal afferent signaling.

Authors:  Guillaume de Lartigue
Journal:  Physiol Behav       Date:  2014-03-18

6.  Lateral habenula projections to dopamine and GABA neurons in the rat ventral tegmental area.

Authors:  Natalia Omelchenko; Roland Bell; Susan R Sesack
Journal:  Eur J Neurosci       Date:  2009-09-29       Impact factor: 3.386

7.  Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP.

Authors:  Andreas T Sørensen; Litsa Nikitidou; Marco Ledri; En-Ju D Lin; Matthew J During; Irene Kanter-Schlifke; Merab Kokaia
Journal:  Exp Neurol       Date:  2008-11-10       Impact factor: 5.330

8.  Ultrastructural analysis of local collaterals of rat ventral tegmental area neurons: GABA phenotype and synapses onto dopamine and GABA cells.

Authors:  Natalia Omelchenko; Susan R Sesack
Journal:  Synapse       Date:  2009-10       Impact factor: 2.562

9.  Comparative Distribution of Relaxin-3 Inputs and Calcium-Binding Protein-Positive Neurons in Rat Amygdala.

Authors:  Fabio N Santos; Celia W Pereira; Ana M Sánchez-Pérez; Marcos Otero-García; Sherie Ma; Andrew L Gundlach; Francisco E Olucha-Bordonau
Journal:  Front Neuroanat       Date:  2016-04-07       Impact factor: 3.856

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.